Hepatitis C treatment uptake among patients who have received opioid substitution treatment: a population-based study | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Hepatitis C treatment uptake among patients who have received opioid substitution treatment: a population-based study

Midgard H, Bramness JG, Skurtveit S, Haukeland JW, Dalgard O. Hepatitis C treatment uptake among patients who have received opioid substitution treatment: a population-based study. PloS One. 2016;11(11):e0166451.

Publication Type:

Journal Article

Authors:

Midgard, Håvard; Bramness, Jørgen G.; Skurtveit, Svetlana; Haukeland, John W.; Dalgard, Olav

Source:

PloS One, Volume 11, Issue 11, p.e0166451 (2016)

Keywords:

Adult, Antipsychotic Agents, Antiviral Agents, Benzodiazepines, Buprenorphine, Naloxone Drug Combination, Disease Notification, Female, Hepacivirus, Hepatitis C, Humans, Interferon-alpha, Methadone, Middle Aged, Norway, Opiate Substitution Treatment, Polyethylene Glycols, Recombinant Proteins, Registries, Ribavirin, Serotonin Uptake Inhibitors, Substance Abuse, Intravenous

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/27846264

Export Citation:

RIS Format

Top